期刊文献+

我院万古霉素药物利用评价 被引量:3

Drug Utilization Evaluation of Vancomycin in Our Hospital
原文传递
导出
摘要 目的:为临床合理使用万古霉素提供参考依据。方法:抽取2013年1月1日-6月30日我院使用万古霉素的出院患者病历,参照国内万古霉素药物利用评价标准,并结合我院实际情况设计的患者使用万古霉素调查表,采用回顾性分析方法,评价万古霉素的使用情况。结果:我院万古霉素临床使用过程中,在患者治疗前后体温监测、白细胞计数、第1次使用48 h以内细菌培养等方面符合标准率均为100%;在用药指征、用法用量及用药疗程、药物相互作用等方面存在不合理现象,其中用药指征符合标准率为63.33%,用法用量及用药疗程符合标准率为51.67%,药物相互作用符合标准率为61.67%。结论:通过开展万古霉素药物利用评价,可发现临床用药过程中存在的问题或不足,有利于促进万古霉素的合理使用。 OBJECTIVE:To provide reference for the reasonable use of vancomycin in our hospital. METHODS:According to the domestic drug utilization evaluation(DUE)criteria of vancomycin,combined with the actual situation of our hospital,the data form was designed to collect the information of vancomycin use in discharged medical records during Jan. 1th-Jun. 30 th,2013,and the utilization of vancomycin in our hospital was evaluated and analyzed retrospectively. RESULTS:During the utilization of vancomycin in our hospital,the qualified rates of temperature monitoring before and after treatment,white blood cell count and bacterial culture within 48 hours after first application were 100%;there were also some unreasonable use of vancomycin such as medication indications,usage and dosage,medication course and drug interaction,among which the qualified rate of the medication indications were 63.33%,that of usage and dosage 51.67%,medication course 51.67%,and drug interaction 61.67%. CONCLUSIONS:Problems or defects can be found in the clinical medication by DUE of vancomycin in our hospital,which is of great significance to the promotion of reasonable use of vancomycin.
出处 《中国药房》 CAS CSCD 2014年第36期3442-3444,共3页 China Pharmacy
关键词 万古霉素 药物利用评价 标准 合理用药 Vancomycin Drug utilization evaluation Critera Rational drug use
  • 相关文献

参考文献6

二级参考文献40

  • 1石庆平,孙利华,丁永为.采用DUR和DUE方法评价本医院恶性淋巴瘤患者的用药情况[J].中国药房,2006,17(21):1630-1632. 被引量:26
  • 2尚磊,江逊,李沪建.老年住院患者院内感染及影响因素分析[J].中国公共卫生,2007,23(7):805-806. 被引量:21
  • 3Rybak MJ . The pharmacokinetic and pharmacodynamic properties of vancomycin [ J ] . Clin Infect Dis, 2006 ;42 ( Suppl. ) : S35 -S39.
  • 4Laiprasert J, Klein K, Mueller BA, et al. Transplacental passage of vancomycin in noninfected term pregnant women [ J ]. Obstet Gynecol, 2007; 109:1105-1110.
  • 5de Jesu's Valle M J, Lo'pez FG, Hurle AD, et al. Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung [ J ]. Antimicrob Agents Chemother, 2007 ; 51 : 3771 - 3774.
  • 6Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic pharmacodynamic surrogate markers to outcome [J]. Clin Pharmacokinet, 1995 ;28 : 143 - 160.
  • 7Hermsen ED. Pharmacokinetic Training packet for Pharmacists [DB/OL]. http ://intranet. nebraskamed. com/careers/education/asp/pdfs/ pk - training packet, pdf. ,2007 - 09 - 12.
  • 8Duffull SB , Begg EJ, Chambers S T,et al. Efficacies of different van- comycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model[ J ]. Antimicrob Agents Chemother, 1994 ; 38 : 2480 - 2482.
  • 9Jeffres MN , Isakow W, Doherty JA, et al. Predictors of mortality for methicillin - resistant Staphylococcus aureus health - care - associated Pneumonia: specific evaluation of vancomycin pharmacokinetic indices [ J ]. Chest, 2006 ; 130:947 - 955.
  • 10Wang JT, Fang CT, Chen YC. Necessity of a loading dose when using vancomycin in critically ill patients [ J ]. J Antimicrob Chemother, 2001 ;47 : 246.

共引文献201

同被引文献23

  • 1刘继斌,曲成毅,王瑞花.基于属性AHM的Topsis综合评价及其应用[J].现代预防医学,2006,33(10):1862-1863. 被引量:47
  • 2卫生部.国家中医药管理局.总后卫生部.抗菌药物临床应用管理办法[Z].2012.
  • 3高永,王玖,石德文.加权TOPSIS法综合评价在Excel中的实现[J].中国卫生统计,2007,24(4):428-429. 被引量:73
  • 4ACQUAH SE, QUAYE L, SAGOE K, et al. Susceptibility of bacterial etiological agents to commonly- used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital [J]. BMC Infect Dis, 2013, 13(1): 89.
  • 5RYBAK MJ, LOMAESTRO BM, ROTSCAHFER JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health- System Pharmacists, and the Society of Infectious Diseases Pharmacists[J]. Clin Infect Dis, 2009, 49(3) : 325-327.
  • 6MEHROTRA N, TANG L, PHELPS SJ, et al. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations[J]. Pharmacotherapy, 2012, 32 (5): 408-419.
  • 7卫生部办公厅.北京市医疗机构处方专项点评指南(试行)[Z].卫办医管函[2012]1179 号.2012-12 -26.
  • 8卫生计生委.抗菌药物临床应用指导原则[Z].2014-07-24.
  • 9Gregoire JP, Moisan J, Potvin L,et al. Effect of drug utilization re-views on the quality of in - hospital prescribing; aquasi - experi-mental study[J]. BMC Health Serv Res,2006,6(33): 1 - 11.
  • 10季闽春,沈晓英,杨耀芳.万古霉素的药代动力学研究进展[J].中国临床药理学杂志,2008,24(6):529-532. 被引量:29

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部